Newsstand Menu

A new drug for Spinal Muscular Atrophy


00:01:59 | March 29, 2012

CSHL Professor Adrian Krainer has developed a new drug for Spinal Muscular Atrophy (SMA), a devastating neuromuscular disease, in collaboration with California-based Ionis Pharmaceuticals. The drug is currently in Phase I clinical trials.